Skip to main content
. 2018 Dec 31;14:81–90. doi: 10.2147/CIA.S187757

Table 2.

Clinical characteristics of the study population by tertiles of hs-cTnT

Tertile 1 (low), ≤0.009 ng/mL (n=253) Tertile 2 (middle), 0.009–0.020 ng/L (n=231) Tertile 3 (high), ≥0.020 ng/L (n=231) P-value
Baseline
Age, years 79.68±6.11 83.04±5.24 84.77±5.37 <0.001
Male sex, % 138 (54.6) 152 (65.8) 180 (77.9) <0.001
Body-mass index, kg/m2 23.36±3.30 23.62±3.30 23.77±3.27 0.38
Heart rate, beats/min 72.28±12.10 74.23±13.21 75.23±13.51 0.056
Systolic pressure, mmHg 131.44±16.02 129.82±16.78 130.99±15.81 0.53
Diastolic pressure, mmHg 70.33±8.58 71.15±9.17 69.87±9.21 0.34
Active smoking 21 (8.3) 18 (7.8) 18 (7.8) 0.97
Comorbidities
SCAD, n (%) 64 (25.3) 78 (33.8) 91 (39.4) 0.004
Hypertension, n (%) 190 (75.1) 182 (78.8) 200 (86.6) 0.006
DM, n (%) 76 (30.0) 97 (42.0) 99 (42.9) 0.005
Cerebral infarction, n (%) 144 (56.9) 136 (58.9) 152 (65.8) 0.11
COPD, n (%) 37 (14.6) 42 (18.2) 59 (25.5) 0.009
CKD, n (%) 43 (17.0) 49 (21.2) 84 (36.4) <0.001
AF, n (%) 30 (11.9) 45 (19.5) 31 (13.4) 0.052
Biochemistry
TC, mmol/L 4.21±0.91 4.09±0.96 3.88±0.96 <0.001
TG, mmol/L 1.13 (0.83–1.56) 1.00 (0.78–1.38) 0.98 (0.74–1.35) 0.004
HDL-C, mmol/L 1.30±0.38 1.23±0.41 1.22±0.39 0.028
LDL-C, mmol/L 2.50±0.76 2.45±0.78 2.26±0.80 0.003
Hb, g/L 131.34±16.64 128.84±19.39 123.52±22.00 <0.001
ALT, mmol/L 14.75 (11.45–18.55) 14.10 (10.20–18.70) 14.40 (10.60–21.40) 0.54
eGFR 78.45±22.69 76.48±23.59 67.58±27.22 <0.001
Echocardiography
LVEF, % 59.92±3.35 59.33±3.95 57.90±5.35 <0.001
LVMI, g/m2 121.15±24.46 127.98±27.95 132.95±29.81 <0.001

Abbreviations: AF, atrial fibrillation; CKD, chronic kidney disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; Hb, hemoglobin; HDL-C, high-density-lipoprotein cholesterol; hs-cTnT, high-sensitivity cardiac troponin T; LDL-C, low-density-lipoprotein cholesterol; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; SCAD, stable coronary artery disease; TC, total cholesterol; TG, triglycerides.